Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
02/2007
02/07/2007CN1298848C Analog of haemophilus Hin47 with reduced protease activity
02/07/2007CN1298840C Bacilluscoli 0157 gene deficiency bacterin of intestinal hemorrhage
02/07/2007CN1298739C Anti-bacterial agent
02/07/2007CN1298738C Modified morbillivirus V proteins
02/07/2007CN1298723C Amorphous cephalosporin
02/07/2007CN1298719C Purine derivatives, preparation method and pharmaceutical compositions containing same
02/07/2007CN1298714C Process to produce 4-hydroxy-2-oxo-pyrone derivates useful as protease inhibitors
02/07/2007CN1298707C Imidazole and benzimiddzole caspase inhibitors and uses thereof
02/07/2007CN1298703C Cyanopyrolidine derivatives
02/07/2007CN1298388C 单纯疱疹病毒ⅱ型dna疫苗 Herpes simplex virus type ⅱ dna vaccine
02/07/2007CN1298387C Vaccine composition and stabilisation method
02/07/2007CN1298378C External lotion of Chinese traditional medicine for treating inflammation in female reproductive system
02/07/2007CN1298360C Areca pellets for clearing away the lung-heat
02/07/2007CN1298356C Prepared Chinese medicine for treating upper respiratory tract infection
02/07/2007CN1298339C Chinese medicine for treating animals virus and bacterial infectious diseases
02/07/2007CN1298337C Preparation of medicine for parotitis
02/07/2007CN1298323C Fused pyrrolocarbazoles against inflammation
02/07/2007CN1298314C Stable salts of O-acetylsalicylic acid containing basic amino acids II
02/06/2007US7173134 retinoid X receptors ("RXRs"); useful for the treatment of diabetes (NIDDIM) and obesity; for example, 3-{4-[(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)methyl]-2-furyl}-2-propenoic acid
02/06/2007US7173054 Respiratory syncytial virus replication inhibitors
02/06/2007US7173053 effective against the growing number of resistant bacteria, particularly the vancomycin resistant enterococci and beta -lactam antibiotic-resistant bacteria, such as methicillin-resistant Staphylococcus aureus
02/06/2007US7173047 Benzo (f) insoindol derivatives and their use as ep4 receptor ligands
02/06/2007US7173043 Heteroaromate OSC inhibitors
02/06/2007US7173040 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted
02/06/2007US7173034 Drugs for treatment of viral diseases such as Respiratory syncytial virus
02/06/2007US7173028 Pyrimidine derivatives
02/06/2007US7173027 Provide a physiological effect to a subject
02/06/2007US7173022 Treatment of HIV integrase heterocycles for enzyme inhibitors and process of viricides
02/06/2007US7173014 For therapy of HIV infection
02/06/2007US7172893 Virus vectors and methods of making and administering the same
02/06/2007US7172870 Treatment of papillomavirus infections
02/06/2007US7172769 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery
02/06/2007US7172761 Polyvalent immunogen
02/06/2007US7172750 Compositions and methods for the treatment and diagnosis of immune disorders
02/06/2007CA2373291C Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatment
02/06/2007CA2286903C Pharmaceutical compositions for immunosuppression, anticancer and antiviral treatment
02/03/2007CA2555410A1 Compositions and methods for enhancing immunity by chemoattractant adjuvants
02/01/2007WO2007014393A2 Amorphous efavirenz and the production thereof
02/01/2007WO2007013677A1 Potentiator for substance having interferon-like effect
02/01/2007WO2007013487A1 Method of producing bulk colistin powder
02/01/2007WO2007013452A1 Sterilizer selective to cariogenic bacterium, and method for sterilization of cariogenic bacterium
02/01/2007WO2007012285A1 Viral infection resistent single strand deoxynucleosides
02/01/2007WO2007012277A1 Isolated proteins from a traditional chinese medicine yuzhu and use thereof
02/01/2007WO2007012177A1 Zalcitabine (ddc) boosted lamivudine (3tc) compositions for antiretroviral therapy
02/01/2007WO2006134160A3 Synergistic mixtures of aromatic alcohols and derivatives thereof and tropolone (derivatives)
02/01/2007WO2006133654B1 USE OF NF-κB INHIBITOR FOR TREATING SEVERAL DISEASES
02/01/2007WO2006131586B1 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same
02/01/2007WO2005118622A3 Naturally processed measles virus peptides eluted from class ii hla molecules
02/01/2007US20070027304 Mammalian IAP gene family, primers, probes and detection methods
02/01/2007US20070027190 Antibacterial fab i inhibitors
02/01/2007US20070027176 Compositions for veterinary and medical applications
02/01/2007US20070027115 Triazole derivatives useful in therapy
02/01/2007US20070026494 Mammalian IAP gene family, primers, probes and detection methods
02/01/2007US20070026470 Mammalian IAP gene family, primers, probes and detection methods
02/01/2007US20070026422 Vaccine-induced hepatitis B viral strain and uses thereof
02/01/2007US20070026389 Methods for drug discovery, disease treatment, and diagnosis using metabolomics
02/01/2007US20070026018 Methods for treating, preventing and diagnosing Helicobacter infection
02/01/2007US20070026014 Interferon beta in severe acute respiratory syndrome (sars)
02/01/2007US20070025968 Methods for selecting and producing T cell peptide epitopes and vaccines incorporating said selected epitopes
02/01/2007US20070025961 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survival of transplanted hematopoietic stem cell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoclonal antibody and transf
02/01/2007US20070025959 Adjuvant combination formulations
02/01/2007US20070025954 Ionene polymers and their use as antimicrobial agents
02/01/2007US20070025948 Dilution-type sterilizer composition
02/01/2007DE102005034227A1 Verfahren zur Extraktion von Wurzeln der Pflanzengattung Pelargonium, danach hergestelltes Extrakt und Verwendung desselben The same process for the extraction of roots of the plant genus Pelargonium, extract and then produced using
02/01/2007DE102004010219B4 HKI10311129, neues Antibiotikum, Verfahren zu dessen Herstellung und Arzneimittel enthaltend HKI10311129 HKI10311129, new antibiotic, to processes for its preparation and medicines containing HKI10311129
02/01/2007CA2618096A1 Carbohydrate compositions from basidiomycete fungi as biocidal agents active against pathogens
02/01/2007CA2616592A1 Zalcitabine (ddc) boosted lamivudine (3tc) compositions for antiretroviral therapy
02/01/2007CA2616386A1 Single dose use of cd20-specific binding molecules
02/01/2007CA2615777A1 Tfpi fragments as anti-microbial agents
01/2007
01/31/2007EP1747783A1 Oral flora-improving agent, antibacterial agent and growth promoter
01/31/2007EP1747781A1 Stable oral pharmaceutical preparation comprising fosfomycin, which is intended for diabetic patients
01/31/2007EP1747262A1 Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates
01/31/2007EP1747233A1 Compounds for specific viral target
01/31/2007EP1747196A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
01/31/2007EP1747023A2 Methods and compositions for reducing viral genome amounts in a target cell
01/31/2007EP1747020A2 7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists
01/31/2007EP1747019A2 Camptothecin derivatives conjugated in position 20 with integrin antagonists
01/31/2007EP1747009A1 Use of histones for the early diagnosis and/or preventive therapy of virus-infected living cells and a biochip for carrying out said diagnosis
01/31/2007EP1746894A1 Sulphur-containing oils for controlling plant pathogens and stimulating nutrient uptake
01/31/2007EP1509516B1 Inhibitors of the gpib -vwf interaction, their preparation and use
01/31/2007EP1478357B1 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
01/31/2007EP1303541A4 Gel compositions containing metronidazole
01/31/2007EP1034000B1 Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral hiv infection
01/31/2007EP1011689B1 USE OF 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
01/31/2007CN1906302A Genetically modified plants comprising SARS-CoV viral nucleotide sequences and methods of use thereof for immunization against SARS
01/31/2007CN1906299A Immunization against chlamydia infection
01/31/2007CN1906203A Glycosaminoglycan (GAG) mimetics
01/31/2007CN1906199A Diazaindole-dicarbonyl-piperazinyl antiviral agents
01/31/2007CN1904046A Single chain deoxynucleotide of anti human immune deficiency virus
01/31/2007CN1903878A Anti SARS virus human source nature antibody IgG Fab section
01/31/2007CN1903870A Single chain DNA having therapeutic action against virus infection disease
01/31/2007CN1903869A Tibifudine derivative salt and its preparation method and pharmaceutical application
01/31/2007CN1903860A Technology of preparing high purity cefotamei sodium by solvent process and its medical use
01/31/2007CN1903847A 2-alkylsulfide-5-alkyl-6-(1-cyano aromethyl) substituted uracil kind compound, its preparation method and use
01/31/2007CN1903846A Ornidazole derivative used for therapy, its preparation method and use
01/31/2007CN1903372A Three gene combination DNA vaccine for avian infectious bronchitis, and application thereof
01/31/2007CN1903371A DNA vaccine pIBN for avian infectious bronchitis, and application thereof
01/31/2007CN1903370A DNA vaccine pIBS1 for avian infectious bronchitis and application thereof
01/31/2007CN1903363A Mosaic type virus-like particle DNA vaccine
01/31/2007CN1903362A Traditional Chinese medicine for hepatitis A or B patient to transfer positive to negative